Study type: Human research · Status: Verified against declared source
Cerebrolysin in Patients with TBI: Systematic Review and Meta-Analysis
2023
Study scale: Cerebrolysin is a low molecular weight neuropeptide preparation obtained from purified porcine brain proteins that has proven neuroprotective properties in vitro and in vivo, including modeling the permeability of endothelial membranes and anti-inflammatory effects [6,7,8].
Abstract only: Open source record
Product or molecular entity relationships
- Cerebrolysin: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.
Plain-language verified summary
Question
TBI is one of the most common causes of death and failure to return to society according to recent literature.
Methods
TBI is one of the most common causes of death and failure to return to society according to recent literature.
Scale or participants
Cerebrolysin is a low molecular weight neuropeptide preparation obtained from purified porcine brain proteins that has proven neuroprotective properties in vitro and in vivo, including modeling the permeability of endothelial membranes and anti-inflammatory effects [6,7,8].
Key findings
TBI (traumatic brain injury) is one of the most common causes of deaths and failure to return to society according to the latest statistics.
Limitations and uncertainty
TBI is one of the most common causes of death and failure to return to society according to recent literature.
Verified against declared source. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.